NCT Number: NCT06734169
This observational study aims to estimate the prevalence and severity of depression among patients in the Cardiothoracic Surgery Ward in Baghdad City, Iraq, using a self-administered PHQ-9 questionnaire. The main questions it aims to answer are:
What is the prevalence of depression among cardiothoracic surgery patients? How is the severity of depression distributed within this group? Are there specific environmental or demographic factors associated with higher levels of depression?
Participants will:
Fill out the PHQ-9 in order to measure the severity of depressive symptoms at a specific moment in time.
Demographic and clinical variables such as age, gender, socioeconomic status, surgery type, comorbidities, and hospital stay length should be taken to look for a possible relationship with depression.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Baghdad, Iraq
Abdul-Ilah R. Khamis
CONTACT
Abdul-Ilah R. Khamis
PRINCIPAL_INVESTIGATOR
Luma K Mohammed
CONTACT
Mesan Ashraf Hijazy, Student
SUB_INVESTIGATOR
Qusai Sobeih MBBCH
SUB_INVESTIGATOR
Razan Sobeih Student
SUB_INVESTIGATOR
Sally M. Shalaldeh, MBBCH
SUB_INVESTIGATOR
Zainab Najm Radiology resident, M.B.CH.B
SUB_INVESTIGATOR
Depression is a common mental health condition that frequently coexists with chronic illnesses and surgical conditions, including cardiothoracic surgeries, significantly impacting recovery and long-term health outcomes. Studies have established a link between depressive symptoms and adverse postoperative results, including prolonged hospital stays, decreased quality of life, and increased mortality rates. In surgical populations, depression often remains undetected and untreated, exacerbating its negative effects on patient outcomes.
In Iraq, particularly in Baghdad, the prevalence of depression among cardiothoracic surgery patients is not well documented. The region's ongoing socio-economic challenges, coupled with limited access to mental health resources, pose additional barriers to adequate psychological care. Addressing these challenges requires robust data to inform targeted interventions.
The Patient Health Questionnaire-9 (PHQ-9) is a validated and widely used tool for screening depression in clinical and nonclinical populations It consists of nine questions that assess the frequency of depressive symptoms over the past two weeks, with scores ranging from 0 to 27. Diagnostic Cut-off: A score of ≥10 is often used as a threshold for identifying major depressive disorder with a high degree of sensitivity and specificity. Additionally, changes in PHQ-9 scores over time are used to evaluate the effectiveness of treatment. Its applicability in diverse populations makes it suitable for assessing depression among cardiothoracic surgery patients in Baghdad .
Baghdad is a region with limited local data on mental health, making it crucial to understand the mental health burden in surgical populations. This study aims to investigate the prevalence and severity of depression in this patient group, providing critical insights to bridge the gap in mental health care and improve surgical outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.
Proportion of cardiothoracic surgery patients at Al-Kadhimiya Teaching Hospital who exhibit depressive symptoms.
Time frame: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.
The severity of depression in this study will be determined based on the scores obtained from the Patient Health Questionnaire-9 (PHQ-9). The PHQ-9 categorizes depression severity as follows:
Minimal depression: Scores 0-4, indicating little to no symptoms. Mild depression: Scores 5-9, suggesting occasional symptoms that may not significantly affect daily functioning.
Moderate depression: Scores 10-14, indicating more frequent symptoms that can interfere with daily life.
Moderately severe depression: Scores 15-19, showing pronounced symptoms that significantly impact daily activities.
Severe depression: Scores 20-27, with symptoms that are debilitating.
Time frame: Data collection will occur over a 3-months period, with each participant completing the PHQ-9 assessment at a single point during this time frame.
The total score can range from 0 to 27. Higher scores indicate greater severity of depression.
Contact information is provided by the study sponsor or research team.
Al-Nahrain University
Other
Depression Among Cardiothoracic Patients in Baghdad: A Cross-Sectional PHQ-9 Study
Acronym: PHQ-9
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736508
Behavior, Behavioral Symptoms
View Trial DetailsNCT07721064
Behavior, Behavioral Symptoms
Charlottesville, Virginia, United States
View Trial DetailsNCT07469176
Behavior, Behavioral Symptoms
Chicago, Illinois, United States
View Trial DetailsNCT07195292
Behavior, Behavioral Symptoms
Dover, Delaware, United States
View Trial Details